16-18th february 2023
We are covering ASCO GU 2023 | Genitourinary Cancers Symposium
News from ASCO GU 2023
ASCO GU 2022
Lisää uutisia ASCO GU 2021 -symposiumista
Management of Erdafitinib, a pan-FGFR kinase inhibitor, treatment-emergent adverse events
/ Arlene O. Siefker-Radtke